Fenbendazole

Fenbendazole 222mg Capsules – 90 Count 

Each sealed bottle contains 90 capsules, each with 222mg of pharmaceutical-grade Fenbendazole.

Overview of Fenbendazole:

Fenbendazole is a well-known broad-spectrum anthelmintic originally developed for veterinary use. It belongs to the benzimidazole class of compounds and works by disrupting energy production and cellular structure in parasitic organisms. Recently, it has attracted growing interest for its potential therapeutic effects in humans—especially for its promising anti-cancer properties.

Anti-Parasitic Mechanism & Efficacy:

Fenbendazole works by binding to beta-tubulin, disrupting the parasite’s ability to form microtubules—essential for cellular structure and nutrient absorption. This leads to paralysis, starvation, and eventual death of the organism. It has shown efficacy against:

• Intestinal worms: hookworms, whipworms, and roundworms

• Protozoa: emerging evidence suggests some effectiveness

Safety Profile:

Fenbendazole is considered safe for humans at proper dosages. Side effects are usually mild and may include gastrointestinal upset. It has a strong safety record in veterinary use and increasing evidence supports its low toxicity in humans.

Anti-Cancer Potential:

Emerging studies suggest Fenbendazole may inhibit tumor growth through several mechanisms:

• Microtubule disruption: interferes with cancer cell division

• Induces apoptosis: triggers natural cell death in malignant cells

• Blocks glucose uptake: limits energy supply to cancer cells

Promising preclinical research indicates potential benefits for:

• Lung cancer

• Colorectal cancer

• Prostate cancer

• Melanoma

Combination with Ivermectin:

Fenbendazole and Ivermectin appear to work synergistically. While Fenbendazole breaks down cellular structures, Ivermectin targets neurological function in parasites and modulates cancer signaling pathways. This dual action may increase treatment efficacy for both parasitic infections and certain cancers.

Other Potential Benefits:

• Anti-inflammatory: May reduce cytokine-driven inflammation in chronic disease

• Antiviral: Preliminary research suggests activity against select viruses, though more study is needed

• Neuroprotective & Immune Modulating: Still under investigation but promising in early data

Fenbendazole is a promising compound that may offer therapeutic benefits beyond its original use in animal medicine. With its ability to disrupt key biological functions in parasites and potentially in cancer cells, it’s increasingly recognized for its broader health applications. When paired with Ivermectin, the combination may yield enhanced therapeutic effects through complementary mechanisms.